Cryoport, Inc. CYRX Cash Flow

Cryoport, inc. (CYRX)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10
Cash Flows From Operating Activities:
Net loss
-19,887	-18,331	-19,642	-9,317	-9,259	-9,555	-9,567	-9,402	-8,792	-7,899	-9,913	-10,117	-12,192	-13,113	-11,589	-11,830	-9,820	-9,047	-7,694	-6,653	-7,026	-6,531	-6,964	-20,539	-19,565	-19,840	-19,567	-6,160	-6,382	-6,334	-6,847	-7,324	-7,832	-8,020	-7,397	-6,877	-6,152	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
2,939	2,415	1,854	1,276	970	857	766	736	721	664	594	511	432	374	343	291	239	209	186	188	197	208	237	277	311	344	356	388	393	399	397	359	343	319	297	271	245	0	0	0
Amortization of debt discount
273	288	46	30	15	0	0	0	0	6	12	18	24	84	143	203	483	637	609	544	1,368	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unrealized gain on investments in equity securities
11	-101	-104	59	15	-16	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Realized loss on investments in equity securities
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Realized gain on available-for-sale investments
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of debt discount and deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	678	549	524	59	17	35	78	135	197	306	399	470	522	0	0	0
Stock-based compensation expense
-	-	-	-	-	-	-	4,478	3,826	3,547	3,309	3,144	3,099	3,117	3,277	3,114	2,846	2,373	1,645	1,194	881	733	701	688	678	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Warrant inducement and repricing expense
-	-	-	-	-	899	899	899	899	0	2,265	2,265	4,195	4,195	1,929	1,929	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of derivative instruments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20	0	0	0	-	-	-	-	119	-118	-144	-32	49	0	0	0
Fair value of stock options and warrants issued to employees, directors and consultants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-519	-437	-811	-559	0	0	0	-	0	0	0
Change in fair value of derivative instruments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-
Loss on disposal of property and equipment
-307	-274	-384	-435	-424	-397	-281	-198	-189	-186	-97	-78	-54	-169	-152	-177	-168	-47	-47	-14	-16	-15	-15	-17	-16	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Provision for bad debt
46	42	0	0	0	-	-	-	-	-	-	-	-	45	37	42	38	38	36	11	2	25	25	19	24	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable
1,977	3,596	4,314	2,523	1,862	1,958	1,800	2,413	929	441	485	272	489	623	334	300	469	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of cryogenic shippers
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6	0	0	0
Interest accrued on restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0
Accounts receivable, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	45	154	323	434	217	212	70	117	58	68	90	47	52	43	-25	0	0	0
Inventories
237	253	220	209	105	105	40	24	50	25	8	-10	1	74	41	49	70	17	52	66	39	36	15	-14	-9	-25	-12	5	-12	8	13	2	7	0	0	0	-	-	-	-
Prepaid expenses and other current assets
259	344	85	35	200	235	638	214	252	261	-342	19	72	-2	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deposits
132	86	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in operating lease right-of-use assets and lease liabilities
-9	6	9	14	9	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	24	29	26	-3	2	4	-34	-27	-76	-138	-174	-109	71	93	155	0	0	0
Accounts payable and other accrued expenses
-23	570	1,045	1,155	955	405	550	879	-97	123	377	454	418	51	327	400	313	405	-37	-18	209	-197	143	-187	-221	271	143	358	443	-99	-162	-67	-62	388	153	131	-109	0	0	0
Accrued compensation and related expenses
917	641	682	631	678	336	256	304	660	506	260	221	-95	41	1	-45	-199	-222	-165	-61	271	226	207	221	236	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred tax liability
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued compensation and related expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	264	403	166	313	438	187	306	0	0	0
Accrued interest
-	-	-	-	-	-	-	-	-	-1	2	0	9	17	13	-3	-14	1	11	38	57	59	57	96	108	105	106	71	39	43	45	46	60	49	51	54	57	0	0	0
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6,347	-5,881	-6,305	-5,628	-5,295	-5,084	-4,127	-4,056	-3,837	-4,126	-4,380	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by (used in) operating activities
-74	-1,323	-2,424	-2,275	-2,478	-3,352	-4,212	-4,513	-3,816	-3,583	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5,784	-6,244	-6,658	-6,780	-5,845	-5,770	-5,110	-4,811	0	0	0
Cash Flows From Investing Activities:
Purchases of property and equipment
4,810	5,335	5,270	4,523	3,765	2,914	2,317	1,661	1,353	1,714	1,626	1,486	1,288	1,062	1,045	1,203	1,119	716	337	179	70	67	69	7	138	224	246	243	156	89	186	262	262	286	193	175	341	0	0	0
Purchases of short-term investments
54,380	43,195	43,053	15,944	14,934	9,923	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales/maturities of short-term investments
21,773	5,995	3,995	2,000	500	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Patent and trademark costs
82	73	60	62	51	46	68	88	90	85	51	29	15	5	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	125	153	129	105	124	0	0	0
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,050	-1,203	-1,119	-716	-337	-179	-70	-67	-69	-7	-138	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-57,817	-62,927	-64,819	-38,959	-18,251	-12,884	-12,301	-1,749	-1,444	-1,800	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-90	-232	-362	-388	-439	-322	-280	-465	0	0	0
Cash Flows From Financing Activities:
Proceeds from the issuance of Class A and Class B convertible preferred stock, net of offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,607	2,802	1,662	780	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options and warrants
6,924	5,362	4,701	5,239	6,678	6,020	6,987	8,778	5,810	5,151	3,767	25	0	0	0	0	10	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock, net of costs
-	-	-	-	-	-	-	-	-	0	11,405	11,405	11,571	0	2,041	2,041	5,938	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the rights offering, net of offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-989	-998	-1,185	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of related party notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	88	88	102	148	154	160	160	0	0	0
Proceeds from tender offer, net of offering costs
-	-	-	-	-	4,641	4,641	4,641	4,641	0	0	0	0	-	0	0	-	-	80	80	92	158	238	238	326	180	100	100	0	-0	115	439	571	0	0	0	-	-	-	-
Proceeds from issuance of convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,558	4,500	3,909	2,252	1,294	0	0	0	-	-	-	-	-	-	-	-
Repayment of notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	741	915	915	915	173	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,179	1,779	2,273	0	0	0	-	-	-	-
Payment of deferred financing costs
-19	0	308	308	308	288	0	0	0	-	-	-	-	-	-	0	-	-	-	0	-	-	-	395	463	436	326	195	206	128	122	105	158	0	0	0	-	-	-	-
Repayment of finance lease liabilities
31	23	31	26	20	14	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of related-party notes payable
-	-	-	-	-	-	-	-	-	656	754	882	417	405	346	278	292	212	172	112	50	50	50	50	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
75,723	74,150	97,993	101,884	34,521	38,531	14,979	13,420	9,722	15,901	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,664	3,193	2,935	2,507	6,370	7,300	10,350	10,925	0	0	0
Effect of exchange rates on cash and cash equivalents
19	8	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash and cash equivalents
17,850	9,907	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rates on cash and cash equivalents
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayment of related-party notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	128	96	96	96	96	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,895	9,224	8,812	10,818	12,589	7,480	5,233	4,677	3,477	4,077	4,326	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4,501	2,139	1,387	4,473	6,956	2,215	1,035	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net change in cash and cash equivalents
-	-	-	-	-	-	-	-	4,461	10,517	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,744	-4,054	-2,210	-3,283	-4,085	-4,660	85	1,207	4,959	5,648	0	0	0
Cash paid for interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	15	15	40	75	113	136	113	87	39	0	0	0
Cash paid for income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	1	1	1	1	0	0	0
Supplemental Disclosure of Non-Cash Financing Activities:
Net unrealized gain on available-for-sale securities
0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reclassification of realized gain on available-for-sale debt securities to earnings
20	23	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchase of equipment through capital lease obligations
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fixed assets included in accounts payable and accrued liabilities
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in net unrealized gain on available-for-sale securities
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reclassification of realized gain on available-for-sale debt securities to earnings
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Offering costs included in additional paid-in capital and accounts payable and other accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cumulative undeclared preferred dividends recorded upon conversion of Class A convertible preferred stock and Class B convertible preferred stock into common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	1,068	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Release of restricted cash for repayment of convertible debentures payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	251	0	0	0	-	-	0	0	-	-	-	-
Estimated relative fair value of warrants issued in connection with convertible bridge notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	478	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Offering costs included in additional paid-in capital and accounts payable and other accrued expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common stock for accrued board of director compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred financing costs in connection with equity financing
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Fair value of shares issued for services
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	23
Offering costs in connection with convertible preferred stock included in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	0	0	-	-	-	-
Deferred offering costs in connection with secondary public offering included in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-
Accretion of convertible preferred stock beneficial conversion feature and relative fair value of warrants issued in connection with the convertible preferred stock units to accumulated deficit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	4,474	6,376	6,869	8,596	4,864	2,961	2,468	741	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of bridge notes payable and accrued interest into common stock units
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,127	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of convertible debentures payable and accrued interest into convertible preferred stock units
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,766	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cashless exercise of warrants and stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	-	-	-	-